G42 Announces New Joint Venture with Sinopharm CNBG to Produce Hayat-Vax Vaccine in the UAE
Highlights: A new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).
Link to Original Article
https://www.reuters.com/article/health-coronavirus-emirates-china-int-idUSKBN2BL0DI